Showing results (881-890 of 1,147) with videos related to
Sort By:
Pageof 115
Journal of Hepatocellular Carcinoma|June 27, 2019
Post-translational modifiers of liver kinase B1/serine/threonine kinase 11 in hepatocellular carcinomaTeresa Cardoso Delgado, Fernando Lopitz-Otsoa, María Luz Martínez-ChantarJournal of Hepatocellular Carcinoma|October 17, 2018
Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI)Victor Hugo Fonseca de Jesus, Aldo Lourenço Abbade DettinoJournal of Hepatocellular Carcinoma|February 25, 2022
Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular CarcinomaDongdong Xue, Jingzhao Han, Ze Liang, et al.Journal of Hepatocellular Carcinoma|March 7, 2022
MicroRNA-128-3p Mediates Lenvatinib Resistance of Hepatocellular Carcinoma Cells by Downregulating c-MetXin Xu, Wenjing Jiang, Peng Han, et al.Journal of Hepatocellular Carcinoma|September 2, 2025
Screening Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Patients After Tyrosine Kinase Inhibitor Plus PD-1/PD-L1 Antibody Therapy: A Multicenter Retrospective StudyZhe Jin, Xueyan Li, Ling Lv, et al.Journal of Hepatocellular Carcinoma|September 4, 2025
Exploration of the Mechanism of Action of Dendrobium officinale in the Treatment of Liver Cancer Based on Network Pharmacology, Molecular Docking and in vitro ValidationShuimeng Zhan, Xinyan Lu, Hongyan Guo, et al.Journal of Hepatocellular Carcinoma|August 31, 2016
Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patientsMohamed Magdi El-Sadek Ali Atta, Hazem Mahmoud Atta, Magdy Abdel-Mawgoud Gad, et al.Journal of Hepatocellular Carcinoma|May 30, 2017
Screening for hepatocellular carcinoma: patient selection and perspectivesWaleed Fateen, Stephen D RyderJournal of Hepatocellular Carcinoma|April 6, 2023
An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC)Wei Huang, Jia Mei, Yuan-Jie Liu, et al.Journal of Hepatocellular Carcinoma|April 1, 2021
Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular CarcinomaJie Mei, Shao-Hua Li, Qi-Jiong Li, et al.Pageof 115